These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35587162)

  • 41. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
    FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Hu antigen R/interferon-β axis modulates sensitivity of esophageal squamous cancer cells to cisplatin.
    Cui YY; Zhu XF; Zhang S
    Neoplasma; 2022 Mar; 69(2):383-391. PubMed ID: 35225647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TNF‑α‑mediated upregulation of SOD‑2 contributes to cell proliferation and cisplatin resistance in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Liu B; Han X; Li Y; Wang W; Zhang Q; Lv P; Xing L; Shen H; Zhang X
    Oncol Rep; 2019 Oct; 42(4):1497-1506. PubMed ID: 31364751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.
    Lin WC; Chen LH; Hsieh YC; Yang PW; Lai LC; Chuang EY; Lee JM; Tsai MH
    Carcinogenesis; 2019 Jul; 40(7):883-892. PubMed ID: 30576425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma.
    Liu K; Luo Y; Tian H; Yu KZ; He JX; Shen WY
    Tumour Biol; 2014 Feb; 35(2):995-1002. PubMed ID: 24022664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.
    Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G
    Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma.
    Liu T; Li R; Zhao H; Deng J; Long Y; Shuai MT; Li Q; Gu H; Chen YQ; Leng AM
    Oncotarget; 2016 Oct; 7(41):66851-66864. PubMed ID: 27588477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β-Catenin and NF-κB signaling pathway.
    Zhou Y; Xu L; Wang J; Ge B; Wang Q; Wang T; Liu C; Wei B; Wang Q; Gao Y
    Cancer Sci; 2022 Oct; 113(10):3566-3578. PubMed ID: 35879265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulated MEG3 contributes to tumour progression and poor prognosis in oesophagal squamous cell carcinoma by interacting with miR-4261, downregulating DKK2 and activating the Wnt/β-catenin signalling.
    Ma J; Li TF; Han XW; Yuan HF
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1513-1523. PubMed ID: 30990378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway.
    Ai R; Sun Y; Guo Z; Wei W; Zhou L; Liu F; Hendricks DT; Xu Y; Zhao X
    Cancer Biol Ther; 2016 Sep; 17(9):943-54. PubMed ID: 27414086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. JNK2 Promotes Progression of Esophageal Squamous Cell Carcinoma
    Wang L; Guo M; Gao L; Liu K; Bai J; Liu Z
    Curr Pharm Des; 2023; 29(37):2977-2987. PubMed ID: 37957865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNF168 is highly expressed in esophageal squamous cell carcinoma and contributes to the malignant behaviors in association with the Wnt/β-catenin signaling pathway.
    Gou Y; Jin D; He S; Han S; Bai Q
    Aging (Albany NY); 2021 Jan; 13(4):5403-5414. PubMed ID: 33493132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma Aggressiveness and Stem Cell-like Phenotype via Dysregulation of PITX2.
    Zhang JX; Chen ZH; Xu Y; Chen JW; Weng HW; Yun M; Zheng ZS; Chen C; Wu BL; Li EM; Fu JH; Ye S; Xie D
    Clin Cancer Res; 2017 Jan; 23(1):298-310. PubMed ID: 27407092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oseltamivir enhances 5-FU sensitivity in esophageal squamous carcinoma with high SPNS1.
    Yang X; Jiao Y; Zhang Y; Sun M; Gao Y; Zhou Y; Xiao H; Ren J; Zhou Z; Zhai Y; Song B; Zhang L; Kong P
    Biomed Pharmacother; 2024 Apr; 173():116367. PubMed ID: 38460365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma.
    Du Y; Ma Y; Zhu Q; Fu Y; Li Y; Zhang Y; Li M; Feng F; Yuan P; Wang X
    Front Med; 2023 Feb; 17(1):119-131. PubMed ID: 36525138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor.
    Zheng Y; Sang M; Liu F; Gu L; Li J; Wu Y; Shan B
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.